ESE is grateful to BridgeBio
for being a Silver Sponsor of ECE 2026
Please visit them at exhibit booth 32
Session at ECE 2026
Satellite symposium
Monday 11 May 2026, 13:00-14:15 CEST, South Hall 2
Not all hypoparathyroidism is the same: Understanding ADH1
Chair: Neil Gittoes, UK
- Chair introduction, Neil Gittoes (UK)
- ADH1 Uncovered: A Distinct Mechaism of Disease, Brigitte Decallone (Belgium)
- Patient Story: Living with ADH1, Gro-Anita Hindenes (Norway)
- The Kidney Perspective: ADH1-Driven Renal Complications, Jean-Philippe Bertocchio (France)
- Managing ADH1: A Mechanism-Informed Approach, Andrea Palermo (Italy)
- Q&A and Closing Remarks, Neil Gittoes (UK)
Abstracts at ECE 2026
Oral Presentation: Encaleret Restores Mineral Homeostasis in Autosomal Dominant Hypocalcemia Type 1 (ADH1): Primary Results from the Phase 3 CALIBRATE Trial 
Presenting Author: TBC
Oral Presentation: Genetic Testing of Over 400 Individuals with Non-Surgical Hypoparathyroidism Shows Gain-of-Function CASR Variants as the Most Common Genetic Cause Identified
Presenting Author: Arun Mathew
Poster: Autosomal Dominant Hypocalcemia Type 1 and Type 2: Baseline Quality of Life Measures in Adult Participants in the CLARIFY Disease Monitoring Study
ePoster: Epidemiology and clinical management of autosomal dominant hypocalcemia type 1 (ADH1): a systematic literature review